Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines

Title
Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines
Authors
Keywords
esophageal squamous cell carcinoma, epidermal growth factor receptor, Sym004
Journal
Oncotarget
Volume 8, Issue 7, Pages -
Publisher
Impact Journals, LLC
Online
2016-12-28
DOI
10.18632/oncotarget.14209

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now